A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-75
SponsorFred Hutchinson Cancer Center

About this trial

This clinical trial studies whether an intervention that addresses two or more levels of care (multilevel intervention) increases follow-up of abnormal, non-invasive, colorectal cancer (CRC) screening test results. The fecal immunochemical test (FIT) is a non-invasive, stool-based, CRC screening test. FITs are relatively inexpensive and can be completed at home, for these reasons, it is a preferred method of CRC screening in healthcare settings that care for under-resourced patients or have limited colonoscopy access. For FIT-based CRC screening to be effective, abnormal results must be followed by a colonoscopy, however many patients fail to complete this recommended follow-up test. The multilevel intervention addresses barriers to follow-up colonoscopy at the patient and health system levels of care through a CRC screening patient navigator, an educational video, and transportation assistance. The navigator provides patient support and assistance with colonoscopy scheduling. The educational video addresses identified patient fears around colonoscopies. Transportation assistance is offered after the colonoscopy through a rideshare program to address transportation barriers. Therefore, this multilevel intervention may increase follow-up colonoscopy completion in patients with abnormal FIT results.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

PATIENTS: Age >= 45 years old and =< 75 years old

PATIENTS: Receives care at an Harborview Medical Center (HMC) or University of Washington-Kent-Des Moines (UW-KDM) or University of Washington- Federal Way (UW-Federal Way) primary care clinic

PATIENTS: >= 1 month from documented abnormal FIT result

PATIENTS: Has not received a colonoscopy between the abnormal FIT and enrollment

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Best Practice

    Other intervention

    Receive usual care CRC screening program navigation

  • Educational Intervention

    Other intervention

    Receive QR code and link to video addressing fears of colonoscopy

  • Electronic Health Record Review

    Other intervention

    Ancillary studies

  • Interview

    Other intervention

    Ancillary studies

  • Supportive Care

    Other intervention

    Receive rideshare transportation home after colonoscopy

  • Survey Administration

    Other intervention

    Ancillary studies

Treatment groups

682 Participants
are divided into 2 treatment groups
Group A: Group I (usual care)Active comparator 2 interventions
Group B: Group II (usual care, video, rideshare transportation)Experimental treatment 6 interventions

Trial outcomes

Primary outcomes

1

Rate of colonoscopy completion within 6 months

Will descriptively compare the rates of colonoscopy completion at 6 months. Will fit a generalized mixed effects model with a logit link and a random effect for clinic. Will include an indicator variable for the randomized group (usual care versus (vs.) multilevel intervention) and adjust for patient-level clinical and demographic factors (e.g., age, sex, race, ethnicity, primary language, marital status, last primary care visit, insurance) and clinic-level factors (e.g., clinic size, average full-time equivalent providers per clinic, average provider panel size, primary care provider mix (Doctor of Medicine/Doctor of Osteopathic Medicine vs. other advanced degree).

Time frame
At 6 months after randomization
2

Time to colonoscopy completion

Will assess the time to colonoscopy completion in days and compare these times across individual clinics.

Time frame
Beginning 6 months after randomization until study completion

Secondary outcomes

1

Rate of colonoscopy completion > 6 months

Will fit separate generalized mixed effects model for each binary outcome, with a logit link and a random effect for clinic. In all models, will include an indicator variable for the randomized group and adjust for patient-level clinical and demographic factors and clinic-level factors.

Time frame
At 9 and 12 months after randomization
2

Colonoscopy referral: Number of participants referred for a colonoscopy

Will assess colonoscopy referral (yes/no) as the number of participants who have a colonoscopy referral placed after randomization.

Time frame
Up to 18 months after randomization
3

Time to colonoscopy referral (days)

Will assess the number of days from randomization to colonoscopy referral.

Time frame
Up to 18 months after randomization
4

Number of participants who schedule a colonoscopy

Will assess the number of referred participants who schedule a colonoscopy.

Time frame
Up to 18 months after randomization

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Fred Hutchinson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator